IL106943A - Programmed release tablets containing naproxen - Google Patents

Programmed release tablets containing naproxen

Info

Publication number
IL106943A
IL106943A IL10694393A IL10694393A IL106943A IL 106943 A IL106943 A IL 106943A IL 10694393 A IL10694393 A IL 10694393A IL 10694393 A IL10694393 A IL 10694393A IL 106943 A IL106943 A IL 106943A
Authority
IL
Israel
Prior art keywords
naproxen
granulate
tablets according
agents
tablet
Prior art date
Application number
IL10694393A
Other languages
English (en)
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of IL106943A publication Critical patent/IL106943A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL10694393A 1992-09-11 1993-09-07 Programmed release tablets containing naproxen IL106943A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO920315A IT1258143B (it) 1992-09-11 1992-09-11 Compresse a cessione programmata contenenti naproxen

Publications (1)

Publication Number Publication Date
IL106943A true IL106943A (en) 1998-09-24

Family

ID=11338458

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10694393A IL106943A (en) 1992-09-11 1993-09-07 Programmed release tablets containing naproxen

Country Status (20)

Country Link
US (1) US5480650A (is)
EP (1) EP0587065B1 (is)
KR (1) KR970008157B1 (is)
CN (1) CN1088091A (is)
AT (1) ATE148340T1 (is)
AU (1) AU669552B2 (is)
CA (1) CA2105541C (is)
CZ (1) CZ279853B6 (is)
DE (1) DE69307807T2 (is)
DK (1) DK0587065T3 (is)
ES (1) ES2097952T3 (is)
FI (1) FI933975A7 (is)
GR (1) GR3022434T3 (is)
IL (1) IL106943A (is)
IS (1) IS1624B (is)
IT (1) IT1258143B (is)
MX (1) MX9305445A (is)
NO (1) NO304260B1 (is)
NZ (1) NZ248574A (is)
ZA (1) ZA936445B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6153225A (en) * 1998-08-13 2000-11-28 Elan Pharma International Limited Injectable formulations of nanoparticulate naproxen
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
WO2001043726A1 (en) * 1999-12-16 2001-06-21 Trident Technologies, Llc System and method for extended delivery of a therapeutic agent with its receptor loading dose
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2009110005A2 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
CA2765866C (en) * 2008-06-20 2016-06-21 Alphapharm Pty Ltd Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5232705A (en) * 1990-08-31 1993-08-03 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy

Also Published As

Publication number Publication date
CZ279853B6 (cs) 1995-07-12
CZ180693A3 (en) 1994-03-16
DK0587065T3 (da) 1997-06-09
FI933975L (fi) 1994-03-12
FI933975A7 (fi) 1994-03-12
KR970008157B1 (ko) 1997-05-21
ES2097952T3 (es) 1997-04-16
MX9305445A (es) 1994-05-31
CN1088091A (zh) 1994-06-22
NO933177D0 (no) 1993-09-07
EP0587065B1 (en) 1997-01-29
ITBO920315A1 (it) 1994-03-11
EP0587065A1 (en) 1994-03-16
NZ248574A (en) 1995-04-27
AU669552B2 (en) 1996-06-13
CA2105541A1 (en) 1994-03-12
GR3022434T3 (en) 1997-04-30
NO933177L (no) 1994-03-14
IS4069A (is) 1994-03-12
DE69307807D1 (de) 1997-03-13
AU4620293A (en) 1994-03-17
KR940006577A (ko) 1994-04-25
FI933975A0 (fi) 1993-09-10
ATE148340T1 (de) 1997-02-15
ZA936445B (en) 1995-01-31
NO304260B1 (no) 1998-11-23
US5480650A (en) 1996-01-02
DE69307807T2 (de) 1997-05-15
IT1258143B (it) 1996-02-20
ITBO920315A0 (it) 1992-09-11
CA2105541C (en) 1999-01-05
IS1624B (is) 1996-10-18

Similar Documents

Publication Publication Date Title
EP0324981B1 (en) New galenic formulations with programmed release
CA1149742A (en) Sustained release indomethacin
US4814175A (en) Nifedipine combination preparation
AU623560B2 (en) Pharmaceutical granules and drug dosage units made therefrom
US4454108A (en) Prolonged-action multiple-layer tablets
CA1264296A (en) Formulations providing three distinct releases
EP0210540B1 (en) Time-controlled explosion systems and processes for preparing the same
EP0220670B1 (en) Multilayer granule
CA1255223A (en) Pellet formulation
KR950003610B1 (ko) 지속성 디클로페낙나트륨 제제
EP0255002A1 (en) New pharmaceutical formulations with programmed release containing antiphlogistics
CA2143010A1 (en) Multilayer controlled release tablets containing both naproxen and naproxen sodium salt
EP0587065B1 (en) Programmed release tablets containing naproxen
US4859469A (en) Novel galenic forms of verapamil, their preparation and medicines containing said novel galenic forms
JP2860013B2 (ja) 医薬組成物
KR20000036039A (ko) 방출 조절된 [Ｒ-(Ｚ)]-α-(메톡시이미노)-α-(1-아자비시클
EP0156243B1 (en) Controlled-release composition and the preparation thereof
US20060039997A1 (en) Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
KR101990951B1 (ko) 리바스티그민 함유 서방출 의약조성물
GB2155330A (en) Solvent granulation technique for forming solid formulation of nystatin
EP2461801A2 (en) Controlled release pharmaceutical compositions of milnacipran
JPS625915A (ja) 塩酸ジルチアゼム徐放性製剤及びその製法
RU2289422C2 (ru) Фармацевтическая композиция на основе ноопепта
US20250177332A1 (en) Pharmaceutical dosage form of lacosamide
CN121265547A (zh) 一种含他克莫司的微丸药物组合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH1 Patent not in force